Yes, AFR had mentioned Jangho board announced to the Shanghai...

Yes, AFR had mentioned Jangho board announced to the Shanghai stock exchange it already has $857m cash and cash reserves shored up; dedicated to the Healius deal. HLS current dividend yield of close to 4% is more sufficient interest cover debt financing; they can save pocket the profits after extracting cost savings. IMHO while we may settle and sell out for $3.65 it is worth $4.00 to $4.50 for Jangho on AU operations. It gets the China upside for free. What a sweet deal for Jangho. 

 “In a response to a query from the stock exchange, Jangho on Wednesday confirmed it planned to use the $HK1.49 billion ($265 million) in proceeds from the Sundart stake sale to help fund the Healius bid.It also said the company had 2.9 billion yuan ($592million) in cash and "abundant" cash reserves at the end of calendar 2018, denying suggestions its cash supply was "strained".”

A letter signed by the company's board of directors also said the company does not have any major expenditure in the first quarter of the 2019 calendar year. "The cash obtained from this deal [Sundart] will be mainly used to facilitate the acquisition of Australian listed company Healius," the letter said.”

source AFR article titled: Chinese billionaire Liu Zaiwang seeks medical help to revive building empire